• 1
    Kahrilas P, Falk GW, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators. Aliment Pharmacol Ther 2000; 14: 124958.
  • 2
    Richter JE, Kahrilas PJ, Johanson J, et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol 2001; 96: 65665.
    Direct Link:
  • 3
    Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 17280.
  • 4
    Castell DO, Kahrilas PJ, Richter JE, et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 2002; 97: 57583.
    Direct Link:
  • 5
    Katz PO, Castell PO, Marino V, et al. Comparison of the new PPI esomeprazole, the S-isomer of omeprazole, vs. placebo for the treatment of symptomatic GERD (s-GERD). Am J Gastroenterol 2000; 95: 24245.
    Direct Link:
  • 6
    Johnsson F, Hatlebakk JG, Klintenberg A-C, et al. One-week esomeprazole treatment; an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Gastroenterology 2001; 120: A426 (Abstract).